Archives of Neurology · 1995 · 64 citations · 12 references
Life SciencesImmunologyOncologyImmunotherapyNeuro-oncologyNeuroimmunologyCerebellar SystemsImmunosuppressionCerebellar DiseaseDurable Clinical ResponseImmunological ResponseImmunosuppressive CompoundsImmunosuppressive Drug TherapyIntrathecal Immunoglobulin SynthesisParaneoplastic Neurologic SyndromesParaneoplastic Neurological Syndromes
OBJECTIVE: To report the clinical and immunological response to immunosuppressive treatment with cyclophosphamide in two patients with paraneoplastic cerebellar degeneration. DESIGN: Case reports. Clinical and immunological follow-up data available for 4 1/2 years in the first patient and for 2 years in the second patient. SETTING: A 1500-bed university hospital and a 1200-bed university teaching hospital. INTERVENTION: Cyclophosphamide intermittent treatment. MAIN OUTCOME MEASURE: Clinical disability. RESULTS: One of the patients, who was treated from an early stage, recovered completely. The other patient showed a partial clinical response. While the two patients were receiving a maintenance regimen with cyclophosphamide, the conditions of both patients remained stable for at least 2 years. In both patients, intrathecal antibody synthesis declined considerably. CONCLUSION: Early induction of immunosuppressive therapy with cyclophosphamide should be tried in treating patients with paraneoplastic cerebellar degeneration.
12
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis
Howard L. Weiner, G. A. Mackin, E. John Orav et al. · Neurology · 1993 · 248 citations
Pharmacy, Neurology, Pharmacotherapy +11